LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA

A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: ASHFAQ,MUHAMMAD, AHMAD,HAMAD, KHAN,ISLAM ULLAH, MUSTAFA,GHULAM
Lenguaje:English
Publicado: Sociedad Chilena de Química 2013
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072013000400059
record_format dspace
spelling oai:scielo:S0717-970720130004000592014-09-02LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMAASHFAQ,MUHAMMADAHMAD,HAMADKHAN,ISLAM ULLAHMUSTAFA,GHULAM HPLC Acetonitrile Diode Array Detector Rosuvastatin Ezetimibe A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acetonitrile and then separation on a C-18 column. Both the analytes were detected at a wavelength of 240 nm using diode array detector. Mobile phase for the said separation consists of a mixture of 1.5% phosphoric acid and acetonitrile in 30:70, v/v ratio. Linearity was in the range of 0.32-267 mg/mL for rosuvastatin and 0.08-67 mg/mL for ezetimibe with coefficient of determination between 0.9997 and 0.9967. Limit of detection was 0.106 μg/mL for rosuvastatin and 0.026 mg/mL for ezetimibe whereas limit of quantification was 0.32 mg/mL and 0.08 mg/mL for rosuvastatin and ezetimibe respectively. Recovery of both the analytes was greater than 75% with RSD less than 15 %. The total run time was less than five min for the two components. The developed method can be fruitfully employed for the determination of these two drugs in human plasma.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.58 n.4 20132013-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059en10.4067/S0717-97072013000400059
institution Scielo Chile
collection Scielo Chile
language English
topic HPLC
Acetonitrile
Diode Array Detector
Rosuvastatin
Ezetimibe
spellingShingle HPLC
Acetonitrile
Diode Array Detector
Rosuvastatin
Ezetimibe
ASHFAQ,MUHAMMAD
AHMAD,HAMAD
KHAN,ISLAM ULLAH
MUSTAFA,GHULAM
LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
description A simple, precise, sensitive and validated reverse-phase high performance liquid chromatographic (RP-HPLC) method was developed for the simultaneous estimation of rosuvastatin and ezetimibe in human plasma. The method involved protein precipitation and extraction of both drugs from plasma using acetonitrile and then separation on a C-18 column. Both the analytes were detected at a wavelength of 240 nm using diode array detector. Mobile phase for the said separation consists of a mixture of 1.5% phosphoric acid and acetonitrile in 30:70, v/v ratio. Linearity was in the range of 0.32-267 mg/mL for rosuvastatin and 0.08-67 mg/mL for ezetimibe with coefficient of determination between 0.9997 and 0.9967. Limit of detection was 0.106 μg/mL for rosuvastatin and 0.026 mg/mL for ezetimibe whereas limit of quantification was 0.32 mg/mL and 0.08 mg/mL for rosuvastatin and ezetimibe respectively. Recovery of both the analytes was greater than 75% with RSD less than 15 %. The total run time was less than five min for the two components. The developed method can be fruitfully employed for the determination of these two drugs in human plasma.
author ASHFAQ,MUHAMMAD
AHMAD,HAMAD
KHAN,ISLAM ULLAH
MUSTAFA,GHULAM
author_facet ASHFAQ,MUHAMMAD
AHMAD,HAMAD
KHAN,ISLAM ULLAH
MUSTAFA,GHULAM
author_sort ASHFAQ,MUHAMMAD
title LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
title_short LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
title_full LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
title_fullStr LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
title_full_unstemmed LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
title_sort lc determination of rosuvastatin and ezetimibe in human plasma
publisher Sociedad Chilena de Química
publishDate 2013
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072013000400059
work_keys_str_mv AT ashfaqmuhammad lcdeterminationofrosuvastatinandezetimibeinhumanplasma
AT ahmadhamad lcdeterminationofrosuvastatinandezetimibeinhumanplasma
AT khanislamullah lcdeterminationofrosuvastatinandezetimibeinhumanplasma
AT mustafaghulam lcdeterminationofrosuvastatinandezetimibeinhumanplasma
_version_ 1718445506755035136